Expression of the regulatory cell cycle proteins p21, p27, p14, p16, p53, mdm2, and cyclin E in bone marrow biopsies with acute myeloid leukemia. Correlation with patients’ survival

References

Page 1

	Year	Citations
Participation of p53 protein in the cellular response to DNA damage. Michael B. Kastan, Onyinye Onyekwere, D Sidransky, PubMed Dna DamageChemoprevention StrategyApoptosisMolecular BiologyCell Death	1991	3.8K
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation Jamil Momand, Gerard P. Zambetti, David C. Olson, Cell Oncogenic AgentMedicineMolecular BiologyP53 ProteinP53-mediated Transactivation	1992	3.1K
The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2 Francesca J. Stott The EMBO Journal Tumor BiologyAlternative ProductCell RegulationMedicineRegulatory Feedback Loop	1998	1.2K
Aberrant methylation of <i>p16</i> <sup>INK4a</sup> is an early event in lung cancer and a potential biomarker for early diagnosis Steven A. Belinsky, Kristen J. Nikula, William A. Palmisano, Proceedings of the National Academy of Sciences	1998	959
Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. James G. Herman, Curt I. Civin, Jean‐Pierre J. Issa, PubMed Mixed-phenotype Acute LeukemiaPathologyHematological MalignanciesEpigeneticsTumor Biology	1997	410
Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. J A Reed, Frank Loganzo, C R Shea, PubMed Invasive StageCell SignalingCell Cycle ControlMedicineP16 Gene	1995	261
p53 in hematologic malignancies Jarell Imamura, I Miyoshi, HP Koeffler Blood Hematological MalignancyMedicineMalignant Blood DisorderHematologyHematologic Malignancies	1994	261
Suppression of Apoptosis by Dominant Negative Mutants of Cyclin-dependent Protein Kinases W Meikrantz, Robert Schlegel Journal of Biological Chemistry	1996	235
Structural basis of inhibition of CDK–cyclin complexes by INK4 inhibitors Philip D. Jeffrey, L. Tong, Nikola P. Pavletich Genes & Development	2000	234
Regulation of Transcription Functions of the p53 Tumor Suppressor by the mdm-2 Oncogene Jiandong Chen, Jiayuh Lin, Arnold J. Levine Molecular Medicine Transcriptional RegulationOncogenic AgentMedicineTranscription FunctionsMdm-2 Oncogene	1995	213

Page 1